[Ambulatory pulse pressure and left ventricular hypertrophy in patients with essential hypertension]

Yang Cao1, Shui-ping Zhao, Lin Luo

  • 1Department of Cardiovasology, Second Xiangya Hospital, Central South University, Changsha 410011, China.

Hunan Yi Ke Da Xue Xue Bao = Hunan Yike Daxue Xuebao = Bulletin of Hunan Medical University
|December 5, 2003
PubMed

Insights

Ambulatory pulse pressure and aortic root dimension are key factors contributing to left ventricular hypertrophy (LVH) in essential hypertension. Monitoring these metrics can help identify patients at risk for LVH.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Diagnostic Imaging

Context:

  • Essential hypertension is a prevalent cardiovascular condition.
  • Left ventricular hypertrophy (LVH) is a significant predictor of cardiovascular events.
  • Ambulatory blood pressure monitoring and echocardiography are crucial diagnostic tools.

Purpose:

  • To investigate the association between ambulatory pulse pressure, aortic root dimension (AOD), and left ventricular hypertrophy (LVH).
  • To identify specific parameters of ambulatory pulse pressure that correlate with LVH in hypertensive patients.

Summary:

  • This study analyzed 107 essential hypertensive patients using 24-hour ambulatory blood pressure monitoring and echocardiography.
  • Patients with LVH showed significant differences in 24-hour, daytime, and nighttime pulse pressure, as well as AOD, compared to those without LVH.
  • Nighttime pulse pressure and AOD were identified as significant predictors of left ventricular mass index (LVMI).

Impact:

  • Findings highlight the importance of pulse pressure and AOD in the development of LVH.
  • This research can inform clinical practice for risk stratification and management of essential hypertension.
  • Early identification of these factors may lead to interventions aimed at preventing LVH progression and associated complications.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Blood Pressure01:24

Blood Pressure

The movement of blood in a human body, commonly referred to as blood flow, is determined by the volume of blood that traverses a certain section of the bodily system per unit time. It is the rhythmic contraction of the heart's ventricles that primarily instigates this movement. As the ventricles contract, blood is forced into the prominent arteries, which then flow from areas of greater pressure to lower pressure areas. This movement continues into smaller arteries and arterioles and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...